Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study)
about
sameAs
Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseasesGender differences in aspirin use among adults with coronary heart disease in the United StatesOcular bleeding related to warfarin anticoagulation in patients with mechanical heart valve and atrial fibrillationEffect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation.Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).Gastrointestinal bleeding and anticoagulant or antiplatelet drugs: systematic search for clinical practice guidelines.Association between CHADS₂risk factors and anticoagulation-related bleeding: a systematic literature review.Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants.Coronary artery disease, left ventricular hypertrophy and diastolic dysfunction are associated with stroke in patients affected by persistent non-valvular atrial fibrillation: a case-control study.Incidence, clinical impact and risk of bleeding during oral anticoagulation therapyStroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study.Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis.Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.Predictors of gastrointestinal bleeding among patients with atrial fibrillation after initiating dabigatran therapy.Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillationAre the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review.Current anticoagulant safety.Influence of sex on risk of bleeding in anticoagulated patients: a systematic review and meta-analysis.Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs.Revised Framingham Stroke Risk Profile to Reflect Temporal Trends.Clinical features and endoscopic findings in patients with actively bleeding colonic angiodysplasia.Warfarin therapy and perioperative transfusion requirement with bleeding amount in patients undergoing cardiac surgery with cardiopulmonary bypass: a retrospective study.Antithrombotic treatment in atrial fibrillation.Colonic Angiodysplasia with a Huge Submucosal Hematoma in the Sigmoid Colon.Qing Dai attenuates nonsteroidal anti-inflammatory drug-induced mitochondrial reactive oxygen species in gastrointestinal epithelial cells.Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults - a systematic review.Monascus purpureus induced apoptosis on gastric cancer cell by scavenging mitochondrial reactive oxygen species.Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) study.Gastrointestinal haemorrhage in atrial fibrillation patients: impact of quality of anticoagulation control.Sex differences in spontaneous reports on adverse bleeding events of antithrombotic treatment.Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil.
P2860
Q28182631-3E1CE837-137C-4507-8D98-1940C3661751Q28220649-39A978B3-27F7-4D72-A88B-BA3CBD51AFBCQ28222062-B026FA0F-B603-4AE6-A8C2-4F37EF7E643BQ34233473-A8E4554F-C9C2-4DEE-8323-C7D4FDE4EA35Q34388959-367D2005-80C7-422D-B51A-C6DD2192172CQ34667405-C057DF16-3A55-4F96-B32B-1D1EA27FB0ADQ35016262-F4B391FD-CA74-458D-A90F-F69AB7EC6D33Q35093560-E6977A03-1122-46A9-AF81-E8BD1C39EC64Q35252790-F9488EA2-B3C5-413F-8A62-92A75FEB0B24Q35575180-047C3738-FC0C-4D51-A784-C34EAABAEDC9Q36283049-D2D0A80A-165C-49BD-9E40-6F6E5A857B4EQ36341724-A19F2578-C4C0-4CB5-B59B-E77390284D86Q36501841-10ECE8D8-62AC-40B2-B41C-70F8EB03523CQ36571742-8526B6A6-8AB4-4839-BF78-1504FD812C31Q36608284-15D14A80-81BA-4DDE-8D30-F5F2BB784DDAQ37890023-08562C36-C761-49AC-AAE7-0DA4C8F70812Q37990564-F9F0F42F-BBA2-4294-A828-539D900D80AAQ38224507-74B20DA8-B5DA-423B-9C1B-FD67CB31F9BFQ38955911-EF2829C9-2E57-4352-AB37-C46F22939FFAQ40350544-61886591-BEDC-43DC-B3E3-F22D8345F489Q41218873-FFE00C99-14EB-42A8-AEE5-2A4712013968Q41433715-11DF626B-57EC-44C4-B902-CFC046277C28Q41878910-18C2433F-4458-41E8-ACEA-094057798475Q41884535-EBBA507E-4DC4-4C37-BDCC-7753A2964040Q42151586-65488ECD-C4FC-4586-9DF5-2A52CD4845CBQ42676674-B034409A-A585-47F3-82B4-EF24CC4B9210Q46248313-423BEFFB-5CA6-4FEB-89E0-2D231AE2556FQ47938006-3E4424C0-9E27-4936-8061-A11254C8F6B2Q48021946-B37D4760-506D-4B5E-BE3C-AF3C4C909737Q51505075-BC3415B9-5668-44A5-97A6-C08E10061F07Q53255324-906C1997-110B-408F-B4A0-276EB7990B1A
P2860
Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study)
description
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im Oktober 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: October 2004)
@en
vedecký článok (publikovaný 2004/10/01)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/10/01)
@nl
наукова стаття, опублікована в жовтні 2004
@uk
مقالة علمية (نشرت في أكتوبر 2004)
@ar
name
Warfarin and aspirin use and t ...... n (the Framingham Heart Study)
@ast
Warfarin and aspirin use and t ...... n (the Framingham Heart Study)
@en
Warfarin and aspirin use and t ...... n (the Framingham Heart Study)
@nl
type
label
Warfarin and aspirin use and t ...... n (the Framingham Heart Study)
@ast
Warfarin and aspirin use and t ...... n (the Framingham Heart Study)
@en
Warfarin and aspirin use and t ...... n (the Framingham Heart Study)
@nl
prefLabel
Warfarin and aspirin use and t ...... n (the Framingham Heart Study)
@ast
Warfarin and aspirin use and t ...... n (the Framingham Heart Study)
@en
Warfarin and aspirin use and t ...... n (the Framingham Heart Study)
@nl
P2093
P50
P3181
P1476
Warfarin and aspirin use and t ...... n (the Framingham Heart Study)
@en
P2093
Colleen Sam
Daniel Levy
Jarvis W Lambert
Ralph B D'Agostino
P304
P3181
P356
10.1016/J.AMJCARD.2004.06.038
P407
P577
2004-10-01T00:00:00Z